Literature DB >> 24486836

Peri-partum reference ranges for ROTEM(R) thromboelastometry.

N M de Lange1, L E van Rheenen-Flach, M D Lancé, L Mooyman, M Woiski, E C van Pampus, M Porath, A C Bolte, L Smits, Y M Henskens, H C Scheepers.   

Abstract

BACKGROUND: Post-partum haemorrhage (PPH) causes rapidly developing deficiencies in clotting factors and contributes to substantial maternal morbidity and mortality. Rotational thromboelastometry (ROTEM(®)) is increasingly used as a point of care coagulation monitoring device in patients with massive haemorrhage; however, there are limited data on reference ranges in the peri-partum period. These are required due to the haemostatic changes in pregnancy.
METHODS: In a Dutch multi-centre trial, 161 subjects were included; blood samples were obtained during labour (T1) and within 1 h of delivery (T2). Reference ranges of ROTEM(®) INTEM, EXTEM, FIBTEM, and APTEM were set and correlation with laboratory results was investigated using the guidelines of the International Federation of Clinical Chemistry.
RESULTS: Reference ranges were obtained for clotting time (CT), clot formation time (CFT), α-angle, clot firmness at 10 and 20 min (A10, A20), maximum clot firmness (MCF), and maximum lysis (ML). These were comparable from centre to centre, and between T1 and T2. Reference ranges T1: EXTEM: CT 31-63 s, CFT 41-120 s, and MCF 42-78 mm. INTEM: CT 109-225 s, CFT 40-103, and MCF 63-78 mm. FIBTEM: CT 31-79 s and MCF 13-45 mm. APTEM: CT 33-62 s, CFT 42-118, and MCF 61-79 mm.
CONCLUSIONS: Reference values for ROTEM(®) parameters are reported. The previously published correlation between FIBTEM parameters and plasma fibrinogen levels by the Clauss method is confirmed. Further research is needed to define threshold values for haemostatic therapy in the course of PPH. Clinical trial registration NTR 2515 (http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=2515).

Entities:  

Keywords:  blood, coagulation; haemostasis; post-partum haemorrhage; reference values; thromboelastography

Mesh:

Year:  2014        PMID: 24486836     DOI: 10.1093/bja/aet480

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  12 in total

1.  Coagulation parameters during the course of severe postpartum hemorrhage: a nationwide retrospective cohort study.

Authors:  Ada Gillissen; Thomas van den Akker; Camila Caram-Deelder; Dacia D C A Henriquez; Kitty W M Bloemenkamp; Moniek P M de Maat; Jos J M van Roosmalen; Joost J Zwart; Jeroen Eikenboom; Johanna G van der Bom
Journal:  Blood Adv       Date:  2018-10-09

Review 2.  Postpartum hemorrhage: Blood product management and massive transfusion.

Authors:  Benjamin K Kogutt; Arthur J Vaught
Journal:  Semin Perinatol       Date:  2018-11-14       Impact factor: 3.300

Review 3.  Risk stratification for pregnancy-associated venous thromboembolism: Potential role for global coagulation assays.

Authors:  David O'Keefe; Hui Yin Lim; Lisa Hui; Prahlad Ho
Journal:  Obstet Med       Date:  2021-08-05

Review 4.  Peripartum Haemorrhage: Haemostatic Aspects of the New German PPH Guideline.

Authors:  Heiko Lier; Christian von Heymann; Wolfgang Korte; Dietmar Schlembach
Journal:  Transfus Med Hemother       Date:  2017-11-15       Impact factor: 3.747

5.  [Transfusion strategy for patients with severe postpartum hemorrhage: a retrospective study of 47 cases].

Authors:  Hosni Khouadja; Wissem Rouissi; Mohamed Mahjoub; Jaballah Sakhri; Dhafer Beletaifa; Khaled Ben Jazia
Journal:  Pan Afr Med J       Date:  2016-11-16

6.  Peripartum Haemorrhage, Diagnosis and Therapy. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry No. 015/063, March 2016).

Authors:  Dietmar Schlembach; Hanns Helmer; Wolfgang Henrich; Christian von Heymann; Franz Kainer; Wolfgang Korte; Maritta Kühnert; Heiko Lier; Holger Maul; Werner Rath; Susanne Steppat; Daniel Surbek; Jürgen Wacker
Journal:  Geburtshilfe Frauenheilkd       Date:  2018-04-26       Impact factor: 2.915

7.  How Can Rotational Thromboelastometry as a Point-of-Care Method Be Useful for the Management of Secondary Thromboprophylaxis in High-Risk Pregnant Patients?

Authors:  Lucia Stanciakova; Miroslava Dobrotova; Pavol Holly; Jana Zolkova; Lubica Vadelova; Ingrid Skornova; Jela Ivankova; Tomas Bolek; Matej Samos; Marian Grendar; Jan Danko; Peter Kubisz; Jan Stasko
Journal:  Diagnostics (Basel)       Date:  2021-05-03

Review 8.  Massive hemorrhage management-a best evidence topic report.

Authors:  Tomas Vymazal
Journal:  Ther Clin Risk Manag       Date:  2015-07-27       Impact factor: 2.423

9.  Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity.

Authors:  Gerhardus J A J M Kuiper; Marie-Claire F Kleinegris; René van Oerle; Henri M H Spronk; Marcus D Lancé; Hugo Ten Cate; Yvonne M C Henskens
Journal:  Thromb J       Date:  2016-01-14

10.  Haematological and fibrinolytic status of Nigerian women with post-partum haemorrhage.

Authors:  Ian Roberts; Haleema Shakur; Bukola Fawole; Modupe Kuti; Oladapo Olayemi; Adenike Bello; Olayinka Ogunbode; Taiwo Kotila; Chris O Aimakhu; Tolulase Olutogun; Beverley J Hunt; Sumaya Huque
Journal:  BMC Pregnancy Childbirth       Date:  2018-05-09       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.